Trial
NCT04334967
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
Phase IVSUSPENDEDSAFETYConfidence: MEDIUM
Sponsor
Providence Health & Services
Collaborators
Center for Outcomes Research and Education; Providence Cancer Center, Earle A. Chiles Research Institute
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
suspected unfavorable risk/benefit assessment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-16